Your email has been successfully added to our mailing list.

×
0 0 0 0.0141414141414142 0.0101010101010101 0.0070707070707071 0.00585858585858584 -0.0505050505050505
Stock impact report

Blackstone invests $2 bln in Alnylam Pharma [Reuters]

Blackstone Inc. (BX) 
Last blackstone inc. earnings: 4/23 06:56 am Check Earnings Report
Company Research Source: Reuters
Blackstone invests $2 bln in Alnylam Pharma April 13 (Reuters) - Blackstone Group Inc said on Monday it invested $2 billion in Alnylam Pharmaceuticals Inc through an equity-and-debt deal, giving the drugmaker a financial boost to develop its experimental therapies. Under the deal, Blackstone purchased 50% of the royalties on global sales of Alnylam's cholesterol therapy inclisiran, currently under review by the U.S. Food and Drug Administration. ( reut.rs/3ckcTyF ) Show less Read more
Impact Snapshot
Event Time:
BX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BX alerts
Opt-in for
BX alerts

from News Quantified
Opt-in for
BX alerts

from News Quantified